Premier Research

Premier Research is a contract research organization (CRO) that supports pharmaceutical, biotech, and medical device companies in bringing their products to market. With a workforce of approximately 1,000 employees, the company operates in over 20 countries, providing specialized expertise in therapeutic areas such as rare diseases, cell therapy, oncology, dermatology, and neuroscience. Premier Research offers a range of services including product development, regulatory consulting, and clinical research support, helping clients navigate complex challenges in the industry. The company's focus on delivering industry insight, global compliance, and therapeutic knowledge positions it as a valuable partner for innovators in the biopharmaceutical sector.

Ludo Reynders Ph.D

CEO

3 past transactions

Health Decisions

Acquisition in 2021
Health Decisions is a full-service CRO specializing in clinical studies of therapeutics for women’s health indications and studies of diagnostics for all therapeutic areas. Health Decisions has focused on women’s health since its inception more than 28 years ago, conducting more than 100 trials in women-only indications such as contraception and postmenopausal vasomotor symptoms. More than a decade ago, Health Decisions expanded into diagnostics studies with a large PMA study of a screening test for high-risk HPV types – the precursors of cervical cancer. Building on the success of the HPV study, Health Decisions has conducted successful diagnostics studies in a variety of other indications in women’s health and beyond, including diagnostics for risk of preterm birth, STIs, a variety of respiratory indications and oncology indications such as colorectal cancer and urothelial carcinoma. Health Decisions has provided services enabling many developers of both women’s health products and diagnostics to meet their development and business goals and looks forward to successful collaborations with many more. They take pride in offering the flexibility to tailor services to each sponsor in a manner that builds on the strengths of both development partners.
Camargo Pharmaceutical Services provides comprehensive drug development services specialized for the 505(b)(2) approval pathway and analogous European processes.

Regulatory Professionals Inc.

Acquisition in 2018
RPI was founded to serve the growing needs of small to mid-size pharmaceutical, biopharmaceutical, and medical device companies, advancing the development and registration of their products worldwide. RPI’s unique ability to create value as a trusted partner and as an integral member of existing scientific, regulatory and publishing teams have earned RPI its reputation as a solutions-oriented advisor.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.